Evidence map›Paper›PMID 40228097›Full record

ArticleMagnetic resonance in medicine2025

In vivo

Hadar Dessau, Talia Harris, Robin A de Graaf, Elton T Montrazi, Hyla Allouche-Arnon, Amnon Bar-Shir

Abstract read
In one paragraph

Article in Magnetic resonance in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Deuterated pH Probes Based on Ketoglutarate for Magnetic Resonance.Journal of the American Chemical Society · 2026
    Article
  3. In vivoMagnetic resonance in medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hadar DessauDepartment of Molecular Chemistry and Materials Science, Weizmann Institute of Science, Rehovot, Israel.
Talia HarrisDepartment of Chemical Research Support, Weizmann Institute of Science, Rehovot, Israel.
Robin A de GraafDepartment of Radiology and Biomedical Imaging, Magnetic Resonance Research Center, New Haven, Connecticut, USA.ORCID 0000-0002-6570-7010
Elton T MontraziDepartment of Chemical and Biological Physics, Weizmann Institute of Science, Rehovot, Israel.
Hyla Allouche-ArnonDepartment of Molecular Chemistry and Materials Science, Weizmann Institute of Science, Rehovot, Israel.
Amnon Bar-ShirDepartment of Molecular Chemistry and Materials Science, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0003-1431-0221

Funding

Israel Science Foundation 1329/20Minerva Foundation
6 · The paper itself

Abstract

purposeDespite growing evidence of the link between elevated levels of trimethylamine-N-oxide (TMAO) and multiple diseases, there is no method with which to spatially monitor its hepatic formation from the interstitially produced trimethylamine (TMA). This study aimed to develop a deuterium metabolic spectroscopy (DMS) and imaging (DMI) approach to detect the TMA-to-TMAO metabolism in vivo.

methodsThe metabolism of

resultsThe spectrally resolved

conclusionThis work shows the ability to use

Indexed as

LiverMagnetic Resonance ImagingMethylaminesAnimalsDeuteriumFemaleHumansMagnetic Resonance SpectroscopyMaleMiceOxygenasesDeuteriumdimethylaniline monooxygenase (N-oxide forming)MethylaminesOxygenasestrimethylaminetrimethyloxamineabdominal/pelvicbiochemistryliver

Identifiers

PMID40228097
PMCPMC12137761

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.